Ernexa Therapeutics Inc (ERNA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ernexa Therapeutics Inc   (NASDAQ: ERNA)


Ernexa Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ernexa Therapeutics Inc's ROI in the second quarter of 2026?
Ernexa Therapeutics Inc recorded a cumulative net loss of $-12 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -281.4%.

Within the Healthcare sector 750 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2868 to 4272.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM - -39.28 % -91.47 % -94.68 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 7 3 4 5
Return On Investment (TTM) -281.4 % -237.36 % -837.59 % -1157.83 % 132436.36 %
ERNA's Overall Ranking # 4272 # 2868 # 3249 # 4191 # 3638
Seq. Investment Change TTM -9.21 % 185.33 % 6.16 % - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -11 -14 -18 -44

ERNA Company Profile >> Back to ERNA Roi Comparisons >> See Annual ERNA Return On Investment



Return On Investment ERNA's Ranking
Within: No.
Industry # 356
Sector # 751
Overall # 4272

Return On Investment Statistics
High Average Low
2.42 %
-276.35 %
-10443.01 %
(Jun 30 2013)   (Jun 30 2025)



  News about Ernexa Therapeutics Inc Return on Investment ROI

Eterna Therapeutics Faces Challenges Amid Leadership Changes and Financial Losses: Can New Vision Propel mRNA Innovation

January 9, 2025

CAMBRIDGE, Mass.—In a bold move, Eterna Therapeutics Inc. recently announced the appointment of Dr. Elena Ratner, a world-renowned expert in obstetrics and gynecology from Yale University, to its Board of Directors. The company is aiming to leverage Dr. Ratner s extensive experience to enhance its ongoing research in ovarian cancer, a critical area of focus for the biotech firm. However, this promising development comes at a time when Eterna is grappling with significant financial hurdles, raising questions about its future trajectory.In the third quarter of 2024, Eterna recorded a cumulative net loss of $45 million, an alarming figure that translates to a negative return on investment (ROI) of -150.91%. These figures underscore the growing financial strain the company is under as it endeavors to maintain its competitive edge in the rapidly evolving biotechnology landscape.





Financial Statements
Ernexa Therapeutics Inc's II. Quarter Investments $ 3 Millions ERNA's Balance sheet
Ernexa Therapeutics Inc's II. Quarter Income $ -4 Millions Quarterly ERNA's Income Statement
ERNA's Income by Division See ERNA's Income by Division


ERNA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2 2 43 15 28
Y / Y Investment Growth 4.85 % -94.52 % 191 % -47.48 % 1910.69 %
Net Income in Millions -14 -45 -22 -25 -123
Y / Y Net Income Growth - - - - -
Annual Return On Investment -576.27 % -1910.73 % -50.91 % -168.06 % -440.05 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ERNA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ERNA's Competitors
Subscribers only: Roi for Ernexa Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ERNA's Customers

Other Ratios
ERNA's Roa ERNA's Inventory Turnover Ratio ERNA's Growth Rates ERNA's Dividend Statistics
ERNA's Profitability Ratios ERNA's Asset Turnover Ratio ERNA's Dividend Growth
ERNA's Roe ERNA's Valuation Ratios ERNA's Financial Strength Ratios ERNA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T17:34:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.